Journal article
SUN-334 Evaluation of the CCK-2 Receptor Agonist 177Lu-PP-F11N for PRRT of Medullary Thyroid Carcinoma: Results of a Phase 0 "Lumed" Study
- Rottenburger, Christof Division of Nuclear Medicine, University Hosp of Basel, Basel, , Switzerland
- Nicolas, Guillaume Division of Nuclear Medicine, University Hosp of Basel, Basel, , Switzerland
- McDougall, Lisa Division of Nuclear Medicine, University Hosp of Basel, Basel, , Switzerland
- Kaul, Felix Division of Nuclear Medicine, University Hosp of Basel, Basel, , Switzerland
- Cachovan, Michal Siemens Healthcare GmbH, Forchheim, , Germany
- Schibli, Roger Center for Radiopharmaceutical Scicencs, Paul Scherrer Institute, Villigen, , Switzerland
- Geistlich, Susanne Center for Radiopharmaceutical Scicencs, Paul Scherrer Institute, Villigen, , Switzerland
- Behe, Martin Center for Radiopharmaceutical Scicencs, Paul Scherrer Institute, Villigen, , Switzerland
- Wild, Damian Division of Nuclear Medicine, University Hosp of Basel, Basel, , Switzerland
- Christ, Emanuel Interdisciplinary Endocrinology, University Hosp of Basel, Basel, , Switzerland
- 2019-4-30
Published in:
- Journal of the Endocrine Society. - The Endocrine Society. - 2019, vol. 3, no. Supplement_1
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.1210/js.2019-SUN-334
- ISSN 2472-1972
- Persistent URL
- https://sonar.ch/global/documents/176445
Statistics
Document views: 8
File downloads: